Liquidia (LQDA): Settles all six lawsuits with United Therapeutics for a net $380.7M
Liquidia has settled all six lawsuits with rival United Therapeutics, so its lung drug Yutrepia can stay on sale for a disease called PAH. The price…
Home/Companies/Liquidia (LQDA)
Liquidia (LQDA)
1 take
All Centiview takes on Liquidia (ticker LQDA): earnings, deals and market news, newest first. Filed under Healthcare; region: US. Each take lists its sources. For information only, not advice.